Kathy Jager, a famous sportswoman, tested positive for anabolic steroids at the 2011 USA National Masters Outdoor Track And Field Championships in Berea. That’s why this woman was banned from participation in competitions. She must not compete till the age of 70. This decision was made by the United States Anti-Doping Agency.
This sportswoman applied steroids because these drugs were recommended by the doctor to stabilize her hormone balance. According to the establishments of World Anti-Doping Agency, athletes can take steroids for medical needs and compete, if they have a Therapeutic Use Exemption (TUE). But Kathy Jager did not receive a TUE that could allow her to utilize steroids without being excluded from competitions.
It is necessary to observe that this athlete doesn’t treat application of anabolic steroids seriously.
She tested positive for methyltestosterone at the 1999 World Association of Veteran Athletes World Championships in Gateshead (Great Britain) after she had broken world records in running of 100 meters. That competition was between sportspersons of 55-59 years old. It was the first time she was banned for application of steroids. Now it was her second time.
As it is known, this athlete utilized EstraTest HS which contained esterified estrogens and methyltestosterone in a tablet.
Kathy Jager noted that she had taken EstraTest for medical needs. But the World Masters Association didn’t believe and banned her from competitions.
The case related to Kathy Jager led to many debates. Some people condemned her for application of banned medicines, others defended her.
When she was banned the first time, she used steroids in order to avoid menopausal problems. The drugs were prescribed by her healthcare provider. Then she ceased applying recommended preparations and began to take herbal preparations.
So, this woman must not participate in competitions till the age of 70 years old. If she had had a TUE, she could compete. But nobody knows whether the World Anti-Doping Agency will give her a TUE or not.
Комментариев нет:
Отправить комментарий